OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations
Angela Santoro, Giuseppe Angelico, Frediano Inzani, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 57-66
Open Access | Times Cited: 14

Showing 14 citing articles:

Incorporating immune checkpoint inhibitors in epithelial ovarian cancer
Giorgio Bogani, Kathleen Moore, I. L. Ray-Coquard, et al.
Gynecologic Oncology (2025) Vol. 193, pp. 30-40
Closed Access | Times Cited: 7

Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer
Che-Wei Chang, Szu‐Ting Yang, Hung‐Hsien Liu, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 5, pp. 651-664
Open Access | Times Cited: 15

Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers
Nooshafarin Shirani, N. Abdi, Matin Chehelgerdi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1

Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access | Times Cited: 1

Artificial Intelligence in Placental Pathology: New Diagnostic Imaging Tools in Evolution and in Perspective
Antonio d’Amati, Giorgio Maria Baldini, Tommaso Difonzo, et al.
Journal of Imaging (2025) Vol. 11, Iss. 4, pp. 110-110
Open Access

Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC)
Gian Franco Zannoni, Giuseppe Angelico, Saveria Spadola, et al.
Gynecologic Oncology (2025) Vol. 194, pp. 1-10
Open Access

Activated immune infiltrates expand opportunities for targeted therapy in p53‐abnormal endometrial carcinoma
Spencer D. Martin, Shelby Thornton, Christine S. Chow, et al.
The Journal of Pathology (2025)
Open Access

Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 2

Therapeutic Prospects of Abemaciclib for Patients with Endometrial Cancer
Ahmad Awada, Sarfraz Ahmad
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5374-5383
Open Access | Times Cited: 2

Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B
Yangyan Sun, Min Wang, Ling Jing, et al.
Human Cell (2024) Vol. 38, Iss. 1
Closed Access | Times Cited: 1

Prognostic significance of the immune microenvironment in endometrial cancer
Miseon Lee, Wonkyung Jung, Jeong-Seok Kang, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 9, pp. 102126-102126
Closed Access

The role of Programmed Death-Ligand 1 (PDL-1) in High-Grade Cervical Intraepithelial Neoplasia (CIN2+) Development and Recurrence: A Systematic Review of Literature about HPV-CIN2+-PDL-1 Axis
Mattia Dominoni, Frediano Inzani, Andrea Gritti, et al.
Pathology - Research and Practice (2024) Vol. 264, pp. 155712-155712
Closed Access

The multiple facets of ovarian high grade serous carcinoma: a review on morphological, immunohistochemical and molecular features.
Angela Santoro, Giuseppe Angelico, Antonio Travaglino, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104603-104603
Closed Access

Page 1

Scroll to top